Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

CYP1A1 genetic polymorphisms and risk for esophageal cancer: a case-control study in central China.

Yun YX, Wang YP, Wang P, Cui LH, Wang KJ, Zhang JY, Dai LP.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6507-12.

2.

[Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].

Dai LP, Wang YP, Wu XB, Wang KJ, Lv QJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Nov;30(11):1198-202. Chinese.

PMID:
20193595
3.
4.

Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an.

Wang AH, Sun CS, Li LS, Huang JY, Chen QS.

World J Gastroenterol. 2002 Feb;8(1):49-53.

5.

Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.

Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J.

Cancer Detect Prev. 2003;27(2):139-46.

PMID:
12670526
6.

Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population.

Al-Achkar W, Azeiz G, Moassass F, Wafa A.

Med Oncol. 2014 May;31(5):889. doi: 10.1007/s12032-014-0889-4. Epub 2014 Mar 27.

PMID:
24671854
7.

Genetic susceptibility and environmental factors of esophageal cancer in Xi'an.

Wang AH, Sun CS, Li LS, Huang JY, Chen QS, Xu DZ.

World J Gastroenterol. 2004 Apr 1;10(7):940-4.

8.

Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan.

Wu MT, Lee JM, Wu DC, Ho CK, Wang YT, Lee YC, Hsu HK, Kao EL.

Br J Cancer. 2002 Aug 27;87(5):529-32.

9.

GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.

Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH.

Cancer Detect Prev. 2007;31(3):233-6. Epub 2007 Jul 23.

10.

Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.

Gong FF, Lu SS, Hu CY, Qian ZZ, Feng F, Wu YL, Yang HY, Sun YH.

Tumour Biol. 2014 Oct;35(10):10351-61. doi: 10.1007/s13277-014-2341-y. Epub 2014 Jul 22.

PMID:
25048966
11.

[Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].

He B, Lin J, Cao L, Wang H, Rao J, Liu Y, Zhang Z.

Wei Sheng Yan Jiu. 2014 May;43(3):393-6, 418. Chinese.

PMID:
24964616
12.

CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.

Aktas D, Guney I, Alikasifoglu M, Yüce K, Tuncbilek E, Ayhan A.

Gynecol Oncol. 2002 Aug;86(2):124-8.

PMID:
12144816
13.

CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.

Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E.

Carcinogenesis. 2003 May;24(5):875-82.

PMID:
12771031
14.

CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.

Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera AM, Gil L.

Cancer Lett. 2001 Dec 10;174(1):35-44.

PMID:
11675150
15.
16.

CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.

Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK.

J Exp Clin Cancer Res. 2011 Oct 20;30:99. doi: 10.1186/1756-9966-30-99. Review.

17.
18.

Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.

Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, Ponder BA, Dunning AM.

Carcinogenesis. 2001 Nov;22(11):1797-800.

PMID:
11698341
19.

The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.

Öztürk T, Kahraman ÖT, Toptaş B, Kisakesen Hİ, Çakalir C, Verim L, Öztürk O, İsbir T.

In Vivo. 2011 Jul-Aug;25(4):663-8.

PMID:
21709011
20.

CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, Nabi S, Masood A, Lone MM, Dar NA.

Tumour Biol. 2014 Jun;35(6):5323-30. doi: 10.1007/s13277-014-1694-6. Epub 2014 Feb 8.

PMID:
24504680

Supplemental Content

Support Center